LISATA THERAPEUTICS, INC. Annual Return On Equity in % from 2012 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lisata Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2024.
  • Lisata Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2024 was -55.7 %, a 46.4% decline year-over-year.
  • Lisata Therapeutics, Inc. annual Return On Equity for 2024 was -55.7 %, a 46.4% decline from 2023.
  • Lisata Therapeutics, Inc. annual Return On Equity for 2023 was -38.1 %, a 45.9% increase from 2022.
  • Lisata Therapeutics, Inc. annual Return On Equity for 2022 was -70.3 %, a 159% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -55.7 -17.7 -46.4% Jan 1, 2024 Dec 31, 2024
2023 -38.1 +32.3 +45.9% Jan 1, 2023 Dec 31, 2023
2022 -70.3 -43.2 -159% Jan 1, 2022 Dec 31, 2022
2021 -27.1 -0.01 -0.04% Jan 1, 2021 Dec 31, 2021
2020 -27.1 +43.6 +61.6% Jan 1, 2020 Dec 31, 2020
2019 -70.7 -31.9 -82.5% Jan 1, 2019 Dec 31, 2019
2018 -38.7 -97.9 -165% Jan 1, 2018 Dec 31, 2018
2017 59.2 +457 Jan 1, 2017 Dec 31, 2017
2016 -397 Jan 1, 2016 Dec 31, 2016
2014 -91 +6.99 +7.14% Jan 1, 2014 Dec 31, 2014
2013 -98 -0.28 -0.29% Jan 1, 2013 Dec 31, 2013
2012 -97.7 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.